Head-to-head · WeighScore
CoreAge Rx vs Hims
By GLP-1 ScorecardUpdated
Score comparison
CoreAge Rx has the higher recorded score — 89.5/100 to 75.6/100.
CoreAge Rx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Advertises pricing across doses with no membership fee, but starting-price displays and FAQ payment/refund promises need to be reconciled with the selected plan and refund policy.
CoreAge Rx scores 89.5/100 (B+).
Before you choose
Hims does not publish a semaglutide price, so its Hims review sets out what it does disclose, while the CoreAge Rx review explains the conditions attached to CoreAge Rx's figure. The semaglutide cost page compares published rates across the field. Ask Hims for a written total before treating either one as the cheaper choice.
If neither one fits, CoreAge Rx vs Hormonally Balanced and DrBrainRx vs Hims compare each of them with another graded program, and the list of alternatives to CoreAge Rx ranks the programs closest to CoreAge Rx on price, features and score. Those pages, like every entry in the review directory, use the same six graded factors, so the scores carry across.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
These are recorded editorial marks, not a measure of clinical outcomes. Current prices and terms may differ from those used in the marks. See the methodology.
The numbers
Swipe or scroll to compare both providers.
| Metric | CoreAge Rx | Hims |
|---|---|---|
| WeighScore | 89.5/100 | 75.6/100 |
| Grade | B+ | C |
| Site position | #1 | #56 |
| Semaglutide | Product page from $79/mo; navigation $99. Confirm selected quote. | Varies (branded medication plus separate membership) |
| Tirzepatide | From $129/mo advertised; confirm selected charge, supply and renewal. | Varies (branded medication plus separate membership) |
| Coverage | US only; therapy-specific state restrictions apply | Selected states; eligibility varies |
| Brand-name access | Not confirmed | Yes |
| Oral / sublingual | Not confirmed | Yes |
Site position #1 · B+
Strengths
- Current product pages advertise starting prices of $79 for semaglutide and $129 for tirzepatide
- Advertises the same price across doses and no membership fee
- Publishes cancellation, fulfillment and refund rules and a way to request the assigned pharmacy
What to consider
- Starting prices vary across public displays and do not establish a selected invoice or usable prescription supply
- FAQ no-rebill and payment-timing statements differ from the subscription and order policy
- FAQ promises a full rejection refund, while policy retains an applicable $50–$100 consultation fee after review begins
- Refund policy makes orders final after approval and pharmacy transmission; Terms also refer to review completion/transmission with policy exceptions. Confirm the cutoff and separate thirty-day documentation limit.
- Actual clinician, dispenser, physical compounder, lab cost and treatment-state eligibility need confirmation
FDAWarning letter issued to Hims & Hers Health, Inc. dba Hims in September 2025. See the FDA warning-letter database.
Strengths
- Branded oral and injectable options
- Medication and membership prices presented separately
What to consider
- Required membership adds to advertised medication prices
- Membership does not guarantee a prescription
Prices and terms can change; confirm them with the provider. Our factor scores may reflect earlier assessments; see our methodology. Not medical advice; see our disclosure.